COVID-19 Vaccination information and resources for GPs

Vaccine product information  

• ATAGI and the Cardiac Society of Australia and New Zealand (CSANZ) have released joint guidance on the risk of myocarditis and pericarditis following Pfizer vaccination following an observed risk observed in overseas studies, especially in males under 30 years of age after the second doses. The Pfizer Product Information has been updated to reflect this. 

• The Product Information (PI) for the AstraZeneca vaccine has been updated to include Capillary Leak Syndrome (CLS) as a contraindication for the AstraZeneca vaccine. Providers should be aware of the information contained in the PI and individuals with a known history of CLS should not be vaccinated with AstraZeneca. 

Consent forms  

• Consent form: https://www.health.gov.au/resources/publications/covid-19-vaccination-consent-form-for-covid-19-vaccination  

Patient information sheets 

• Information on AstraZeneca: https://www.health.gov.au/resources/publications/covid-19-vaccination-information-on-covid-19-astrazeneca-vaccine  

• Information on Pfizer: https://www.health.gov.au/resources/publications/covid-19-vaccination-information-on-covid-19-pfizer-comirnaty-vaccine  

• After your AstraZeneca: https://www.health.gov.au/resources/publications/covid-19-vaccination-after-your-astrazeneca-vaccine  

• After your Pfizer: https://www.health.gov.au/resources/publications/covid-19-vaccination-after-your-pfizer-comirnaty-vaccine  

• Provider information on consent: https://www.health.gov.au/resources/publications/covid-19-vaccination-consent-information-for-providers-covid-19-vaccination-consent-and-faqs  

Clinical guidance and decision guides  

• ATAGI Clinical guidance: https://www.health.gov.au/resources/publications/covid-19-vaccination-atagi-clinical-guidance-on-covid-19-vaccine-in-australia-in-2021  

• COVID-19 vaccine – Clinical considerations: https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines/information-for-covid-19-vaccination-providers/covid-19-vaccine-clinical-considerations  

• Selection of second dose in specific circumstances: https://www.health.gov.au/resources/publications/covid-19-vaccination-clinical-advice-on-the-use-of-a-different-covid-19-vaccine-as-the-second-dose  

• Shared decision making guide – pregnancy: https://www.health.gov.au/resources/publications/covid-19-vaccination-shared-decision-making-guide-for-women-who-are-pregnant-breastfeeding-or-planning-pregnancy  

• Shared decision making guide – frail older people: https://www.health.gov.au/resources/publications/covid-19-vaccination-shared-decision-making-guide-for-frail-older-people-including-those-in-residential-aged-care-facilities   

• Shared decision making guide – palliative care: https://www.health.gov.au/resources/publications/covid-19-vaccination-shared-decision-making-guide-for-people-receiving-palliative-care-or-end-of-life-care   

• Shared decision making guide – immunocompromise: https://www.health.gov.au/resources/publications/atagi-covid-19-vaccination-shared-decision-making-guide-for-people-with-immunocompromise  

• Provider guide on immunocompromise: https://www.health.gov.au/resources/publications/atagi-provider-guide-to-covid-19-vaccination-of-people-with-immunocompromise  

• Primary care guide on TTS: https://www.health.gov.au/resources/publications/covid-19-vaccination-primary-care-approach-to-thrombosis-with-thrombocytopenia-syndrome-after-covid-19-astrazeneca-vaccine  

• Provider information – TTS: https://www.health.gov.au/resources/publications/covid-19-vaccination-information-for-immunisation-providers-on-thrombosis-with-thrombocytopenia-syndrome-tts-following-covid-19-vaccination   

• Patient information – TTS: https://www.health.gov.au/resources/publications/patient-information-sheet-on-astrazeneca-covid-19-vaccine-and-thrombosis-with-thrombocytopenia-syndrome-tts  

Resources for doctors working with Aboriginal and Torres Strait Islander patients 

• Updated guidance on TGA advertising restrictions, explaining how you can inform your patients about different vaccine brands availability in your clinic. This includes social, posters and web content. 

• A video animation in plain English that could be sent to your patients’ emails or used in your clinic waiting room explaining what to expect on your vaccination day, side effects and the need for two doses of the COVID-19 vaccine.  

• A suite of talking points designed for healthcare workers, to assist them with having conversations with patients about COVID-19 vaccines.  

• Updated social resources with suggested captions to use across your social media networks 

Existing resources 

• COVID-19 Vaccination in Pregnant and Breastfeeding Women: https://ranzcog.edu.au/statements-guidelines/covid-19-statement/covid-19-vaccination-information  

• Information for people with disability about COVID-19 vaccines: https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines/information-for-service-providers-workers-and-people-with-disability-about-covid-19-vaccines/information-for-people-with-disability-about-covid-19-vaccines 

• COVID-19 vaccination – Guidance on Myocarditis and Pericarditis after mRNA COVID-19 vaccines: https://www.health.gov.au/resources/publications/covid-19-vaccination-guidance-on-myocarditis-and-pericarditis-after-mrna-covid-19-vaccines  

• Talking to patients about AstraZeneca vaccine: https://www.health.gov.au/resources/publications/talking-to-patients-about-astrazeneca-vaccine  

• ATAGI statement on use of COVID-19 vaccines in an outbreak setting: https://www.health.gov.au/news/atagi-statement-on-use-of-covid-19-vaccines-in-an-outbreak-setting  

• COVID-19 vaccination – updated provider kit for general practices: https://www.health.gov.au/resources/publications/covid-19-vaccination-updated-provider-kit-for-general-practices  

• COVID-19 vaccination – Practice Incentives Program COVID-19 vaccine general practice incentive guidelines: https://www.health.gov.au/resources/publications/covid-19-vaccination-pip-general-practice-incentive-guidelines  

• Joint statement between RANZCOG and ATAGI about COVID-19 vaccination for pregnant women: https://www.health.gov.au/news/joint-statement-between-ranzcog-and-atagi-about-covid-19-vaccination-for-pregnant-women  

• Updated ATAGI advice on administering seasonal influenza vaccines in 2021: https://www.health.gov.au/news/updated-atagi-advice-on-administering-seasonal-influenza-vaccines-in-2021  

• COVID-19 vaccination – Guide to engage and support aged care workers to get a COVID-19 vaccine: https://www.health.gov.au/resources/publications/covid-19-vaccination-guide-to-engage-and-support-aged-care-workers-to-get-a-covid-19-vaccine  

• Weighing up the potential benefits against risk of harm from COVID-19 Vaccine AstraZeneca: https://www.health.gov.au/resources/publications/covid-19-vaccination-weighing-up-the-potential-benefits-against-risk-of-harm-from-covid-19-vaccine-astrazeneca 

• COVID-19 vaccination – AstraZeneca vaccine risk-benefit printable: https://www.health.gov.au/resources/publications/covid-19-vaccination-astrazeneca-vaccine-risk-benefit-printable  

• COVID-19 vaccination – ATAGI guidance on the use of multi-dose vials for COVID-19 vaccination: https://www.health.gov.au/resources/publications/covid-19-vaccination-atagi-guidance-on-the-use-of-multi-dose-vials-for-covid-19-vaccination  

• COVID-19 vaccination – Consent – Information for providers: COVID-19 vaccination consent and FAQs: https://www.health.gov.au/resources/publications/covid-19-vaccination-atagi-immunisation-provider-guide-to-obtaining-informed-consent-for-covid-19-vaccine  

Members are also reminded that if you are part of the vaccine roll out and have any problems, the key point of contact in the Commonwealth to raise these is the Vaccine Operations Centre (VOC) that can be contacted on:  

Phone: 1800 318 308 

Email: COVID19VaccineOperationsCentre@health.gov.au  

Note: The VOC hours of operation are between 7am to 10pm (AEST).